{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:55:05Z","timestamp":1772229305494,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.celrep.2022.110318","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T22:19:26Z","timestamp":1641853166000},"page":"110318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection"],"prefix":"10.1016","volume":"38","author":[{"given":"Kylie M.","family":"Konrath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xizhou","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne N.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Schultheis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neethu","family":"Chokkalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshi","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqiu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Tursi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Adolf-Bryfogle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansi","family":"Purwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma L.","family":"Reuschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Frase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Fry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Maricic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane M.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Iffland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate E.","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent M.P.F.","family":"Humeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor R.F.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Pallesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0527-3804","authenticated-orcid":false,"given":"Daniel W.","family":"Kulp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.110318_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00204-19","article-title":"Human influenza A virus hemagglutinin glycan evolution follows a temporal pattern to a glycan limit","volume":"10","author":"Altman","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2022.110318_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.110318_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.chom.2019.04.003","article-title":"Influenza antigen engineering focuses immune responses to a subdominant but broadly protective viral epitope","volume":"25","author":"Bajic","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2022.110318_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110318_bib5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2021.01.035","article-title":"Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection","volume":"184","author":"Brouwer","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110318_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib7","doi-asserted-by":"crossref","first-page":"e00802-20","DOI":"10.1128\/mSphere.00802-20","article-title":"Competitive SARS-CoV-2 serology reveals most antibodies targeting the spike receptor-binding domain compete for ACE2 binding","volume":"5","author":"Byrnes","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.celrep.2022.110318_bib8","doi-asserted-by":"crossref","first-page":"14695","DOI":"10.1073\/pnas.94.26.14695","article-title":"Development of an epithelium-specific expression cassette with human DNA regulatory elements for transgene expression in lung airways","volume":"94","author":"Chow","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.celrep.2022.110318_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib10","doi-asserted-by":"crossref","first-page":"e1008753","DOI":"10.1371\/journal.ppat.1008753","article-title":"Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates","volume":"16","author":"Cottrell","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.110318_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110318_bib12","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1074\/jbc.RA117.000709","article-title":"Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers","volume":"293","author":"De Taeye","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.110318_bib13","doi-asserted-by":"crossref","first-page":"108933","DOI":"10.1016\/j.celrep.2021.108933","article-title":"Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike","volume":"35","author":"Derking","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.110318_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110318_bib15","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1038\/ncomms13473","article-title":"Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110318_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, disease and diplomacy: GISAID's innovative contribution to global health","volume":"1","author":"Elbe","year":"2017","journal-title":"Glob. Chall."},{"key":"10.1016\/j.celrep.2022.110318_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2022.110318_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1126\/science.1172447","article-title":"Knockout rats via embryo microinjection of zinc-finger nucleases","volume":"325","author":"Geurts","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib20","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/bit.27361","article-title":"Glycosylation as a tool for rational vaccine design","volume":"117","author":"Hariharan","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.celrep.2022.110318_bib21","first-page":"1","article-title":"Self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation COVID-19 vaccines","author":"He","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2022.110318_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.chom.2020.07.002","article-title":"Neutralization of SARS-CoV-2 by destruction of the prefusion spike","volume":"28","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2022.110318_bib23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib24","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1128\/JVI.02614-14","article-title":"Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies","volume":"88","author":"Ingale","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110318_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110318_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14760584.2019.1578216","article-title":"Immunological basis for enhanced immunity of nanoparticle vaccines","volume":"18","author":"Kelly","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.celrep.2022.110318_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.celrep.2022.110318_bib28","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41467-017-01549-6","article-title":"Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding","volume":"8","author":"Kulp","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110318_bib29","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","article-title":"Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies","volume":"5","author":"Lee","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2022.110318_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","article-title":"On the calculation of TCID50 for quantitation of virus infectivity","volume":"36","author":"Lei","year":"2021","journal-title":"Virol. Sin"},{"key":"10.1016\/j.celrep.2022.110318_bib31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2022.110318_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110318_bib33","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1128\/JVI.74.15.6769-6776.2000","article-title":"V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies","volume":"74","author":"Ly","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110318_bib34","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.110318_bib35","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.110318_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"Mccray","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110318_bib37","doi-asserted-by":"crossref","first-page":"187ra70","DOI":"10.1126\/scitranslmed.3005996","article-title":"Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses","volume":"5","author":"Medina","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.110318_bib38","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41467-020-19891-7","article-title":"Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice","volume":"11","author":"Oladunni","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110318_bib39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110318_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110318_bib41","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.110318_bib42","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","article-title":"Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection","volume":"9","author":"Rathnasinghe","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2022.110318_bib43","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bioinformatics\/btaa739","article-title":"CoV-AbDab: the coronavirus antibody database","volume":"37","author":"Raybould","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2022.110318_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.coi.2016.06.002","article-title":"Epitope-focused vaccine design against influenza A and B viruses","volume":"42","author":"Ren","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2022.110318_bib45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110318_bib46","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","article-title":"CTFFIND4: fast and accurate defocus estimation from electron micrographs","volume":"192","author":"Rohou","year":"2015","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.celrep.2022.110318_bib48","doi-asserted-by":"crossref","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.celrep.2022.110318_bib49","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jmb.2011.11.010","article-title":"A Bayesian view on cryo-EM structure determination","volume":"415","author":"Scheres","year":"2012","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.celrep.2022.110318_bib50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.immuni.2020.06.001","article-title":"Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation","volume":"53","author":"Seydoux","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.110318_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110318_bib52","doi-asserted-by":"crossref","first-page":"e20211003","DOI":"10.1084\/jem.20211003","article-title":"Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses","volume":"218","author":"Shinnakasu","year":"2021","journal-title":"J.\u00a0Exp. Med"},{"key":"10.1016\/j.celrep.2022.110318_bib53","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110318_bib54","doi-asserted-by":"crossref","first-page":"100040","DOI":"10.1016\/j.xcrm.2020.100040","article-title":"Rapid generation of neutralizing antibody responses in COVID-19 patients","volume":"1","author":"Suthar","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2022.110318_bib55","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","article-title":"A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110318_bib56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2022.110318_bib57","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.abd7728","article-title":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months","volume":"370","author":"Wajnberg","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib58","doi-asserted-by":"crossref","first-page":"e01533-20","DOI":"10.1128\/JCM.01533-20","article-title":"SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients","volume":"58","author":"Walker","year":"2020","journal-title":"J.\u00a0Clin. Microbiol"},{"key":"10.1016\/j.celrep.2022.110318_bib59","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110318_bib60","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110318_bib61","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1164\/rccm.201007-1184OC","article-title":"Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice","volume":"183","author":"Wanzeck","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.celrep.2022.110318_bib62","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib63","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.celrep.2022.110318_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110318_bib65","first-page":"1","article-title":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications","author":"Wu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.celrep.2022.110318_bib66","doi-asserted-by":"crossref","first-page":"108274","DOI":"10.1016\/j.celrep.2020.108274","article-title":"An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain","volume":"33","author":"Wu","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.110318_bib67","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib68","doi-asserted-by":"crossref","first-page":"101399","DOI":"10.1016\/j.isci.2020.101399","article-title":"Incorporation of a novel CD4+ helper epitope identified from Aquifex aeolicus enhances humoral responses induced by DNA and protein vaccinations","volume":"23","author":"Xu","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2022.110318_bib69","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/2326-6066.CIR-20-0061","article-title":"A DNA-launched nanoparticle vaccine elicits CD8(+) T-cell immunity to promote in\u00a0vivo tumor control","volume":"8","author":"Xu","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2022.110318_bib70","doi-asserted-by":"crossref","first-page":"1902802","DOI":"10.1002\/advs.201902802","article-title":"In\u00a0vivo assembly of nanoparticles achieved through Synergy of structure-based protein engineering and synthetic DNA generates enhanced adaptive immunity","volume":"7","author":"Xu","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2022.110318_bib71","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.110318_bib72","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.4049\/jimmunol.2000840","article-title":"Discordance between serum neutralizing antibody titers and the recovery from COVID-19","volume":"205","author":"Yazici","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.110318_bib73","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib74","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2020.10.012","article-title":"Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies","volume":"538","author":"Yuan","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2022.110318_bib75","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110318_bib76","doi-asserted-by":"crossref","first-page":"18149","DOI":"10.1038\/s41598-020-74949-2","article-title":"A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2022.110318_bib77","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2022.110318_bib78","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41594-020-0480-y","article-title":"Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient","volume":"27","author":"Zhou","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2022.110318_bib79","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:34:28Z","timestamp":1761910468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2211124722000298"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.110318","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.28.441474","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.110318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"110318"}}